Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Molecular Partners Ag (MOLN) EBITDA: 2022-2024

Historic EBITDA for Molecular Partners Ag (MOLN) over the last 3 years, with Dec 2024 value amounting to -$69.6 million.

  • Molecular Partners Ag's EBITDA rose 31.41% to -$14,992 in Q3 2025 from the same period last year, while for Sep 2025 it was -$61.7 million, marking a year-over-year increase of 3.76%. This contributed to the annual value of -$69.6 million for FY2024, which is 2.27% down from last year.
  • Per Molecular Partners Ag's latest filing, its EBITDA stood at -$69.6 million for FY2024, which was down 2.27% from -$68.0 million recorded in FY2023.
  • Over the past 5 years, Molecular Partners Ag's EBITDA peaked at $121.0 million during FY2022, and registered a low of -$69.6 million during FY2024.
  • Moreover, its 3-year median value for EBITDA was -$68.0 million (2023), whereas its average is -$5.5 million.
  • Data for Molecular Partners Ag's EBITDA shows a maximum YoY crashed of 156.21% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Molecular Partners Ag's EBITDA stood at $121.0 million in 2022, then tumbled by 156.21% to -$68.0 million in 2023, then dropped by 2.27% to -$69.6 million in 2024.